Clinical Trials Logo
Clinical Research
NCT ID: NCT04789187 Recruiting - Clinical trial for Breast Cancer

Exercise, Cancer and Cognition: The ECCO-Study

ECCO
Start date: December 1, 2019
Phase: N/A
Study type: Interventional

The "ECCO"-study evaluates the efficacy of simultaneous controlled exercise during neo/-adjuvant chemotherapy in breast cancer patients and its effects on neurocognition. In this study the investigators examine the benefits of the individualized high intensity training program on a cancer related cognitive impairment. Changes in patients' cognition are evaluated by neuropsychological testing. Possible structural changes are detected with MRI volumetry. Biomarkers connected to Cancer Related Cognitive Impairment (CRCI) and chemotherapy related inflammatory processes which impair cognition, respectively, will be assessed.

NCT ID: NCT04769050 Recruiting - Clinical trial for Breast Cancer

Dynamic Observational Study With PET of 68Ga-HER2-affibody in Anti-HER2 Treatment

Start date: February 18, 2021
Phase:
Study type: Observational

Dynamic observationaL study with PET of 68Ga-HER2-affibody in anti-HER2 treatment

NCT ID: NCT04744506 Recruiting - Clinical trial for Breast Cancer

Targeted Resection of Axillary Metastatic Lymph Nodes After Breast Cancer Neoadjuvant Chemotherapy

Start date: November 15, 2020
Phase: N/A
Study type: Interventional

This study is a multi-center, prospective, self-controlled study, to evaluate the feasibility of targeted axillary lymph node resection (TAD) guided by tissue marker clip with methylene blue single tracer after neoadjuvant chemotherapy in T1-4N1M0 breast cancer patients. Evaluate the accuracy and false negative rate of TAD, comparing with sentinel lymph node biopsy, and explore a new axillary-preserving mode after neoadjuvant chemotherapy for breast cancer.